From the Journals

PT may lower risk of long-term opioid use after knee replacement


 

Physical therapy: Underexplored option for pain in knee replacement

One finding caught the researchers slightly off guard: There was no association between active physical therapy and reduced odds of long-term opioid use. “From prior studies, at least in people with knee osteoarthritis, we know that active interventions were more useful than passive interventions,” Dr. Kumar said.

That said, he added that there is still some professional uncertainty regarding “the right type or the right components of physical therapy for managing pain in this population.” Regardless, he believes their study emphasizes the benefits of PT as a pain alleviator in these patients, especially those who have previously used opioids.

“Pharmaceuticals have side effects. Injections are not super effective,” he said. “The idea behind focusing on physical therapy interventions is that it’s widely available, it does you no harm, and it could potentially be lower cost to both the payers and the providers.”

The authors acknowledged their study’s limitations, including not adjusting for opioid use within the 90 days after surgery as well as the different outcome assessment periods for pre-TKR and post-TKR PT exposures. In addition, they admitted that some of the patients who received PT could have been among those less likely to be treated with opioids, and vice versa. “A randomized clinical trial,” they wrote, “would be required to disentangle these issues.”

The study was supported by grants from the National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Dr. Kumar reported receiving grants from the National Institutes of Health during the conduct of the study and grants from Pfizer for unrelated projects outside the submitted work. The full list of author disclosures can be found with the original article.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Could an osteoporosis drug reduce need for hip revision surgery?
MDedge Rheumatology
Meta-analysis: No evidence that SNRIs relieve back pain
MDedge Rheumatology
OA risk-reduction program targets injured knees
MDedge Rheumatology
Success in achondroplasia spurs testing vosoritide in more growth disorders
MDedge Rheumatology
COVID-19 vaccination in RMD patients: Safety data “reassuring”
MDedge Rheumatology
Weight cycling linked to cartilage degeneration in knee OA
MDedge Rheumatology
Intramuscular glucocorticoid injections seen as noninferior to intra-articular in knee OA
MDedge Rheumatology
High tibial osteotomy achieves sustained improvements in knee OA
MDedge Rheumatology
AAOS updates guidelines for nonoperative knee OA treatment
MDedge Rheumatology
PRP injections don’t top placebo for ankle osteoarthritis
MDedge Rheumatology